JAGX
Price:
$1.11
Market Cap:
$10.26M
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for shor...[Read more]
Industry
Biotechnology
IPO Date
2015-05-12
Stock Exchange
NASDAQ
Ticker
JAGX
According to Jaguar Health, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 28.36M. This represents a change of -82.71% compared to the average of 164.06M of the last 4 quarters.
The mean historical Enterprise Value of Jaguar Health, Inc. over the last ten years is 1.34B. The current 28.36M Enterprise Value has changed 110.98% with respect to the historical average. Over the past ten years (40 quarters), JAGX's Enterprise Value was at its highest in in the March 2021 quarter at 13.54B. The Enterprise Value was at its lowest in in the September 2014 quarter at 0.
Average
1.34B
Median
842.07M
Minimum
34.12M
Maximum
4.17B
Discovering the peaks and valleys of Jaguar Health, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.25%
Maximum Annual Enterprise Value = 4.17B
Minimum Annual Increase = -93.71%
Minimum Annual Enterprise Value = 34.12M
Year | Enterprise Value | Change |
---|---|---|
2023 | 34.12M | -93.71% |
2022 | 542.25M | -80.65% |
2021 | 2.80B | 47.65% |
2020 | 1.90B | 681.92% |
2019 | 242.73M | -47.44% |
2018 | 461.78M | -71.37% |
2017 | 1.61B | 168.15% |
2016 | 601.51M | -44.44% |
2015 | 1.08B | -74.01% |
2014 | 4.17B | 1.25% |
The current Enterprise Value of Jaguar Health, Inc. (JAGX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.13B
5-year avg
1.10B
10-year avg
1.34B
Jaguar Health, Inc.’s Enterprise Value is greater than Onconova Therapeutics, Inc. (4.51M), greater than iBio, Inc. (26.47M), greater than GeoVax Labs, Inc. (27.26M), less than Ocugen, Inc. (319.33M), greater than eFFECTOR Therapeutics, Inc. (3.83M), greater than Virios Therapeutics, Inc. (1.92M), less than Zura Bio Limited (42.42M), greater than Navidea Biopharmaceuticals, Inc. (-2504975.00), greater than ZyVersa Therapeutics, Inc. (2.58M), greater than Tonix Pharmaceuticals Holding Corp. (8.24M), greater than Acasti Pharma Inc. (5.04M), greater than Diffusion Pharmaceuticals Inc. (-1447403.00), greater than Phio Pharmaceuticals Corp. (-2451521.00), greater than Sonnet BioTherapeutics Holdings, Inc. (1.13M), greater than 180 Life Sciences Corp. (1.19M), greater than Cardio Diagnostics Holdings, Inc. (6.50M), less than Vaxart, Inc. (181.18M), less than VBI Vaccines Inc. (39.99M),
Company | Enterprise Value | Market cap |
---|---|---|
4.51M | $20.90M | |
26.47M | $15.35M | |
27.26M | $28.68M | |
319.33M | $328.16M | |
3.83M | $188.18K | |
1.92M | $4.94M | |
42.42M | $230.86M | |
-2504975.00 | $100.08K | |
2.58M | $2.70M | |
8.24M | $3.14M | |
5.04M | $24.44M | |
-1447403.00 | $8.98M | |
-2451521.00 | $2.25M | |
1.13M | $4.53M | |
1.19M | $1.89M | |
6.50M | $6.94M | |
181.18M | $201.33M | |
39.99M | $1.87M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jaguar Health, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jaguar Health, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Jaguar Health, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Jaguar Health, Inc. (JAGX)?
What is the 3-year average Enterprise Value for Jaguar Health, Inc. (JAGX)?
What is the 5-year average Enterprise Value for Jaguar Health, Inc. (JAGX)?
How does the current Enterprise Value for Jaguar Health, Inc. (JAGX) compare to its historical average?